デフォルト表紙
市場調査レポート
商品コード
1687594

迅速微生物検査の市場規模、シェア、成長分析:製品別、方法別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Rapid Microbiology Testing Market Size, Share, and Growth Analysis, By Product, By Method, By Application, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
迅速微生物検査の市場規模、シェア、成長分析:製品別、方法別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

迅速微生物検査の世界市場規模は、2023年に54億6,000万米ドルと評価され、2024年の59億4,000万米ドルから2032年には116億6,000万米ドルに成長し、予測期間中(2025-2032年)にCAGR 8.8%で成長する見通しです。

迅速微生物検査の需要は、都市化の進展とそれに伴う水質汚染に対応して高まっており、米国で年間約135万人の感染者を出しているサルモネラ菌による感染症など、さまざまな病気の原因となっています。インキュベーションや大がかりなラボサービスを必要とせず、リアルタイムで評価できる迅速な生物学的分析の必要性が、ますます明らかになってきています。さらに、リステリア症汚染の可能性によるRizo Lopez Foodsのような最近のリコールによって浮き彫りにされた、包装食品の世界の消費量の増加は、迅速な微生物検査法の必要性を強化しています。この動向は、多様な生産工程における安全性と管理を強化する効果的な微生物検査ソリューションの必要性を強調しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 規制情勢
  • 特許分析

迅速微生物検査市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • 装置
  • 試薬とキット
  • 消耗品

迅速微生物検査市場規模:方法別& CAGR(2025-2032)

  • 市場概要
  • 成長ベースの迅速微生物検査
  • 細胞コンポーネントベースの迅速微生物検査
  • 核酸ベースの迅速微生物検査
  • 実行可能性に基づく迅速微生物検査

迅速微生物検査市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 臨床疾患診断
  • 食品および飲料の検査
  • 医薬品およびバイオテクノロジー試験
  • 環境試験
  • 調査用途

迅速微生物検査市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院および診断研究所
  • 製薬・バイオテクノロジー企業
  • 契約調査機関(CRO)
  • 学術研究機関
  • 食品・飲料会社

迅速微生物検査市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Becton, Dickinson and Company(USA)
  • bioMerieux SA(France)
  • Danaher Corporation(USA)
  • Abbott Laboratories(USA)
  • Thermo Fisher Scientific Inc.(USA)
  • Merck KGaA(Germany)
  • Sartorius AG(Germany)
  • Bruker Corporation(USA)
  • QuidelOrtho Corporation(USA)
  • Charles River Laboratories(USA)
  • Neogen Corporation(USA)
  • Don Whitley Scientific Limited(UK)
  • Rapid Micro Biosystems, Inc.(USA)
  • Gradientech(Sweden)
  • rqmicro AG(Switzerland)
  • Colifast AS(Norway)
  • Serosep Limited(Ireland)
  • Solus PerkinElmer(USA)
  • BTNX Inc.(Canada)
  • R-Biopharm AG(Germany)

結論と提言

目次
Product Code: SQMIG35A2782

Global Rapid Microbiology Testing Market size was valued at USD 5.46 billion in 2023 and is poised to grow from USD 5.94 billion in 2024 to USD 11.66 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The demand for rapid microbiology testing is escalating in response to growing urbanization and related water pollution, which contributes to various diseases, including those caused by Salmonella, responsible for approximately 1.35 million annual infections in the U.S. Current detection methods are often slow and imprecise, complicating efforts to manage water-borne illnesses. The need for swift biological analysis-capable of real-time assessment without incubation or extensive lab services-is becoming increasingly apparent. Moreover, the global rise in packaged food consumption, highlighted by recent recalls like Rizo Lopez Foods' due to potential listeriosis contamination, reinforces the necessity for prompt microbial testing methods. This trend underscores the critical need for effective microbiology solutions that enhance safety and control within diverse production processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Microbiology Testing Market Segments Analysis

Global Rapid Microbiology Testing Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Instruments, Reagents and Kits and Consumables. Based on Method, the market is segmented into Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing. Based on Application, the market is segmented into Clinical Disease Diagnostics, Food and Beverage Testing, Pharmaceutical and Biotechnology Testing, Environmental Testing and Research Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes and Food and Beverage Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Microbiology Testing Market

The global surge in infectious diseases, particularly hospital-acquired infections (HAIs) and antibiotic resistance, has significantly heightened the demand for rapid microbiological testing. Moreover, escalating investments in healthcare, notably in developing areas, demonstrate a commitment from both governmental bodies and private entities to enhance diagnostic capabilities for effectively managing outbreaks. Additionally, the growing awareness of the importance of early diagnostic accuracy, which positively influences patient outcomes, is further driving the swift adoption of comprehensive microbiological solutions. Consequently, these factors collectively contribute to the robust growth of the global rapid microbiology testing market.

Restraints in the Global Rapid Microbiology Testing Market

Although the global rapid microbiology testing market offers numerous benefits, the high costs associated with advanced testing equipment present a significant barrier for numerous laboratories and healthcare facilities. The financial burden of acquiring sophisticated systems, coupled with ongoing expenses related to infrastructure and maintenance, particularly in low-income and underdeveloped areas, hampers widespread adoption. Additionally, smaller laboratories and hospitals often experience budget limitations, making it challenging to transition from conventional diagnostic methods to rapid microbiological testing solutions. As a result, these financial constraints negatively impact the overall growth potential of the rapid microbiological testing market.

Market Trends of the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market is witnessing a significant trend towards integrating artificial intelligence (AI) and big data analytics, revolutionizing the landscape of microbial diagnostics. This innovation enables AI-driven platforms to process vast quantities of diagnostic data in real time, resulting in quicker and more precise outcomes. Furthermore, such advancements facilitate predictive assessments, which allow healthcare providers to proactively identify potential infection outbreaks and tailor their interventions accordingly. As a result, the demand for sophisticated rapid testing solutions is surging, driving growth in the market and further enhancing the efficiency of microbial detection and management in various sectors, particularly healthcare.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Rapid Microbiology Testing Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Instruments
  • Reagents and Kits
  • Consumables

Global Rapid Microbiology Testing Market Size by Method & CAGR (2025-2032)

  • Market Overview
  • Growth-Based Rapid Microbiology Testing
  • Cellular Component-Based Rapid Microbiology Testing
  • Nucleic Acid-Based Rapid Microbiology Testing
  • Viability-Based Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Clinical Disease Diagnostics
  • Food and Beverage Testing
  • Pharmaceutical and Biotechnology Testing
  • Environmental Testing
  • Research Applications

Global Rapid Microbiology Testing Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Food and Beverage Companies

Global Rapid Microbiology Testing Market Size & CAGR (2025-2032)

  • North America (Product, Method, Application, End User)
    • US
    • Canada
  • Europe (Product, Method, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Method, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Method, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Method, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Don Whitley Scientific Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rapid Micro Biosystems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradientech (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • rqmicro AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colifast AS (Norway)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serosep Limited (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solus PerkinElmer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTNX Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • R-Biopharm AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations